Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience

Abstract

Various polymorphisms in cytokine genes have recently been investigated as candidate risk factors in allogeneic hematopoetic stem cell transplantation (allo-HSCT). We retrospectively analyzed specific polymorphisms in genes for interleukin (IL)-10, IL-6, tumor-necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ) in a pediatric cohort of 57 histocompatibility leucocyte antigen (HLA)-identical sibling myeloablative transplants. Both recipient and donor genotypes were tested for association with graft-versus-host disease (GVHD) by statistical methods including Cox regression analysis. We found a significant association between the IL-10 promoter haplotype polymorphisms at positions -1082, -819 and -592 with the occurrence of severe (grades III–IV) acute GVHD (aGVHD). Recipients with the haplotype GCC had a statistically significant decreased risk of severe aGVHD (hazard risk (HR)=0.20, 95% confidence interval (CI): 0.06–0.67) in comparison with patients with other IL-10 haplotypes (P=0.008). Transplant-related mortality at 1 year was significantly lower in recipients with this haplotype (HR=0.17, 95% CI: 0.012–0.320) versus other IL-10 haplotypes (P=0.03), whereas overall survival was not influenced by IL-10 haplotype polymorphisms. In multivariate analysis, the presence of the IL-10 GCC haplotype was found as the only variable associated with a statistically significant decreased hazard of severe aGVHD development (P=0.02, HR=0.21, 95% CI: 0.05–0.78). These results suggest that pediatric patients possessing the IL-10 GCC haplotype may be protected from the occurrence of severe aGVHD in the setting of matched sibling HSCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Ferrara JL, Levine JE, Reddy P, Holler E . Graft-versus-host-disease. Lancet 2009; 373: 1550–1561.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E . Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 2004; 127: 479–490.

    Article  CAS  PubMed  Google Scholar 

  3. Dickinson AM, Charron D . Non-HLA immunogenetics in hematopoietic stem cell transplantation. Curr Opin Immunol 2005; 17: 517–525.

    Article  CAS  PubMed  Google Scholar 

  4. Yilmaz V, Yentur SP, Saruhan-Direskeneli G . IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005; 30: 188–194.

    Article  CAS  PubMed  Google Scholar 

  5. Holler E, Roncarolo MG, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 237–241.

    Article  CAS  PubMed  Google Scholar 

  6. Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM . Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92: 3943–3948.

    CAS  PubMed  Google Scholar 

  7. Keen LJ, DeFor TE, Bidwell JL, Davies SM, Bradley BA, Hows JM . Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood 2004; 103: 3599–3602.

    Article  CAS  PubMed  Google Scholar 

  8. Ambruzova Z, Mrazek F, Raida L, Jindra P, Vidan-Jeras B, Faber E et al. Association of IL-6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2009; 44: 227–235.

    Article  CAS  PubMed  Google Scholar 

  9. Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nagatoshi Y, Sakata N et al. Polymorphisms of growth factor-beta 1 and transforming growth factor-beta 1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant 2002; 30: 665–671.

    Article  CAS  PubMed  Google Scholar 

  10. Goyal RY, Lin Y, Schultz KR, Ferrell RE, Kim Y, Fairfull L et al. Tumor necrosis factor-α gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: A pediatric blood and marrow transplant consortium study. Biol Blood Marrow Transplant 2010; 16: 927–936.

    Article  CAS  PubMed  Google Scholar 

  11. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  12. Kubistova Z, Mrazek F, Tudos Z, Kriegova E, Ambruzova Z, Mytilineos J et al. Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. Int J Immunogenet 2006; 33: 261–267.

    Article  CAS  PubMed  Google Scholar 

  13. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PG, Hutchinson IV . An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1–8.

    Article  CAS  PubMed  Google Scholar 

  14. Kurreeman FA, Schonkeren JJ, Heijmans BT, Toes RE, Huizinga TW . Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level. Hum Mol Genet 2004; 13: 1755–1762.

    Article  CAS  PubMed  Google Scholar 

  15. Visentainer JE, Lieber SR, Persoli LB, Vigorito AC, Aranha FJ, de Brito Eid KA et al. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation. Exp Hematol 2003; 31: 1044–1050.

    Article  CAS  PubMed  Google Scholar 

  16. Lin MT, Storer B, Martin PJ, Tseng LH, Cooley T, Chen PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201–2210.

    Article  CAS  PubMed  Google Scholar 

  17. Akdis CA, Blaser K . Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001; 103: 131–136.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Socié G, Loiseau P, Tamouza R, Janin A, Bousson M, Gluckman E et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699–705.

    Article  PubMed  Google Scholar 

  19. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM . Recipient tumour necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA matched sibling bone marrow transplants. Blood 1999; 98: 3941–3946.

    Google Scholar 

  20. Bertinetto FE, Dall'Omo AM, Mazolla GA, Rendine S, Berrino M, Bertola B et al. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenet 2006; 33: 375–384.

    Article  CAS  PubMed  Google Scholar 

  21. Dickinson AM, Pearce KF, Norden J, O'Brien SG, Holler E, Bickeboeller H et al. Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukaemia. Haematologica 2010; 95: 922–927.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bettens F, Passweg J, Gratwohl A, Chalandon Y, Helg C, Chapuis B et al. Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic transplantation. Transplantation 2006; 81: 1261–1267.

    Article  CAS  PubMed  Google Scholar 

  23. Kim DH, Lee NY, Sohn SK, Baek JH, Kim JG, Suh JS et al. IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation. Transplantation 2005; 79: 1615–1622.

    Article  CAS  PubMed  Google Scholar 

  24. Seo KW, Kim DH, Sohn SK, Lee NY, Chang HH, Kim SW et al. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1089–1095.

    Article  CAS  PubMed  Google Scholar 

  25. Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, Minelli C et al. How to use an article about genetic association, A: Background concepts. JAMA 2009; 301: 74–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evgenios Goussetis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goussetis, E., Varela, I., Peristeri, I. et al. Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience. Cell Mol Immunol 8, 276–280 (2011). https://doi.org/10.1038/cmi.2011.4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2011.4

Keywords

This article is cited by

Search

Quick links